In vivo antimutagenic effect of ascorbic acid against mutagenicity of the common antiamebic drug diiodohydroxyquinoline. | Mutat Res;222(3): 219-22, 1989 Mar. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

In vivo antimutagenic effect of ascorbic acid against mutagenicity of the common antiamebic drug diiodohydroxyquinoline.

Ghaskadbi, S; Vaidya, V G.

Affiliation

Ghaskadbi S; Department of Zoology, M.A.C.S. Research Institute, Pune, India.

Mutat Res ; 222(3): 219-22, 1989 Mar.

Article in En | MEDLINE | ID: mdl-2493578

Subject(s)

Ascorbic Acid/administration & dosage; Hydroxyquinolines/toxicity; Iodoquinol/toxicity; Mutation; Administration, Oral; Animals; Ascorbic Acid/therapeutic use; Bone Marrow/drug effects; Erythrocytes, Abnormal/drug effects; Male; Mice; Mice, Inbred Strains; Micronucleus Tests

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Ascorbic Acid / Iodoquinol / Hydroxyquinolines / Mutation Limits: Animals Language: En Journal: Mutat Res Year: 1989 Document type: Article Affiliation country: India Country of publication: Netherlands

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Ascorbic Acid / Iodoquinol / Hydroxyquinolines / Mutation Limits: Animals Language: En Journal: Mutat Res Year: 1989 Document type: Article Affiliation country: India Country of publication: Netherlands